NICE refuses AstraZeneca breast cancer drug on NHS
 

Britain’s National Institute for Health and Clinical Excellence (NICE) has refused another breast cancer drug from routine NHS use. This was not met with enthusiasm by the cancer charities which said that drugs of this type are “particularly valuable”.

More...

Re: NICE refuses AstraZeneca breast cancer drug on NHS
 

Ugg...I've seen patients in forums stable on Faslodex for multiple years. Time to change NICE to NOOSE